1. Catalogs
  2. Nanodigmbio
  3. Nanodigmbio-μCaler HotSpot Panel v1.0

Nanodigmbio-μCaler HotSpot Panel v1.0

Nanodigmbio-μCaler HotSpot Panel v1.0

Nanodigmbio-μCaler HotSpot Panel v1.0

Product catalog summary
Introduction
The μCaler HotSpot Panel v1.0 is designed to target 'hotspot' regions of tumor mutations, covering 49 genes associated with carcinogenesis and tumor suppression. It utilizes the μCaler Hybrid Capture System to enhance capture efficiency and reduce experimental time, leading to cost savings in sequencing.

Gene List
The panel includes genes such as AKT1, ALK, APC, BRAF, EGFR, KRAS, and TP53, among others, with probes covering approximately 25 Kb of the genome.

Performance
Capture performance was evaluated using the LDT OncoOne Pan-tumor gDNA Standard. Sequencing was conducted on the Illumina Novaseq 6000 platform, with results showing high mappability, on-target rates, and coverage uniformity.

Variant Analysis
The panel demonstrated consistency in allele frequency capture compared to reference standards, with specific variants such as NRAS_Q61H and KRAS_G12D showing observed allele frequencies close to reference values.

Ordering Information
The μCaler HotSpot Panel v1.0 is available in two configurations: 16 reactions (Catalog# 1101402) and 96 reactions (Catalog# 1101401).

Statement
This product is for research use only and not for diagnostic procedures. Unauthorized reproduction or translation of this document is prohibited.
See more

Catalog excerpts

Nanodigmbio-μCaler HotSpot Panel v1.0-1

HotSpot Detection | ^Caler HotSpot Panel v1.0IntroductionliCaler HotSpot Panel v1.0 targets the“hotspot" regions of tumor mutation, involving 49 genes related to carcinogenesis and tumor suppressor, with probes covering approximately 25 Kb of the genome.This Panel is designed for use with the pCaler Hybrid Capture System. Based on the novel pCaler targeted enrichment system, the liCaler HotSpot Panel v1.0 delivers improved capture efficiency, consistent and excellent capture performance, and significantly reduces experimental time, enabling more efficient sequencing and cost savings.Gene list AKT1 ALK GNAQ GNAS MTOR NRAS Mappability On-target 0.2x mean 0.5x mean depth depth Depth of coverage (mean = 100) Fig 1. Capture performance of ^Caler HotSpot Panel v1.0. LDT OncoOne Pan-tumor gDNA Standard (LDT Bioscience, LDT900) was used for pre-library preparation with NadPrep® EZ DNA Library Preparation Kit v2 paired with NadPrep® Universal Stubby Adapter (UDI) Module; 500 ng/pre-library (1-piex) input was used, following the user manual of liCaler hybrid capture. Sequencing was performed using Illumina Novaseq 6000, PE150. The BWA was used for alignment to the reference genome hg38 and On-target rate was calculated by the number of reads. A. Mappability, On-target rate and Target covered; B. Coverage uniformity. Note: OncoOne Pan-cancer gDNA Standard (LDT Bioscience, LDT900) include a negative control (LDT Bioscience, LDT898) and a positive control (LDT Bioscience, LDT899). Sequencing platform: Illumina Novaseq 6000,PE150.

 Open the catalog to page 1
Nanodigmbio-μCaler HotSpot Panel v1.0-2

Allele frequency Observed allele frequency (%) Observed allele frequency (%) Variant analysis Allele frequency for reference (%) Fig 2. Consistency of the allele frequency in μCaler HotSpot Panel v1.0 capture data with the reference frequency of the standards. Pre-libraries were prepared using the NadPrep EZ DNA Library Preparation Kit v2, μCaler HotSpot Panel v1.0 was used to complete hybridization capture. Sequencing was performed using Illumina Novaseq 6000, PE150. Note: The samples were: OncoOne Pan-cancer gDNA Standard (LDT Bioscience, LDT900). Ordering Information Product μCaler HotSpot...

 Open the catalog to page 2

All Nanodigmbio catalogs and technical brochures

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.